The Summit
23rd - 25th July 2012
Summit Venue
Barton Creek Resort & Spa, Austin, Texas
The Next Generation Pharmaceutical Summit has grown to become the standard for senior level pharmaceutical executives looking to share ideas with peers, build partnerships with industry thought leaders, and hear from key experts on how to address some of their most pressing challenges in discovery and development, clinical research and beyond.
Past and Present VIP Attendees
VP of Global Clinical Research Operations
Pfizer Inc.
Chief Infectious Disease
NIH
VP of Clinical Development, Oncology
sanofi-aventis
VP Clinical Development
Celgene
VP Clinical Sciences & Study Operations
GSK
SVP Medical & Scientific Affairs
Takeda Pharmaceuticals
VP Clinical Research
Boehringer Ingelheim Pharmaceuticals, Inc.
SVP Discovery and Exploratory Clinical Research
Bristol Myers-Squibb
VP Global Pharmacovigilance & Epidemiology – Medical Safety
Bristol-Myers Squibb
VP Early Drug Development
Celgene
VP of Discovery Medicine
GSK
VP Translational Medicine & Pharmacogenomics
Eli Lilly
Global Head Oncology Clinical Imaging
Novartis
Chief Medical Officer and SVP
Schering-Plough Corporation
SVP Discovery Research and Chief Scientific Officer
Schering-Plough Corporation
VP Early Development and Clinical Pharmacology
Wyeth
Assistant VP Translational Medicine
Wyeth
Director
Tufts Center for the Study of Drug Development
Group Vice President of Global Clinical Research
Schering-Plough Corporation
COO and SVP of Research and Development
Biolex
VP of Global Clinical Research Operations
Pfizer Inc.
Chief Infectious Disease
NIH
VP of Clinical Development, Oncology
sanofi-aventis
VP Clinical Development
Celgene
VP Clinical Sciences & Study Operations
GSK
SVP Medical & Scientific Affairs
Takeda Pharmaceuticals
VP Clinical Research
Boehringer Ingelheim Pharmaceuticals, Inc.
SVP Discovery and Exploratory Clinical Research
Bristol Myers-Squibb
VP Global Pharmacovigilance & Epidemiology – Medical Safety
Bristol-Myers Squibb
VP Early Drug Development
Celgene
VP of Discovery Medicine
GSK
VP Translational Medicine & Pharmacogenomics
Eli Lilly
Global Head Oncology Clinical Imaging
Novartis
Chief Medical Officer and SVP
Schering-Plough Corporation
SVP Discovery Research and Chief Scientific Officer
Schering-Plough Corporation
VP Early Development and Clinical Pharmacology
Wyeth
Assistant VP Translational Medicine
Wyeth
Director
Tufts Center for the Study of Drug Development
Group Vice President of Global Clinical Research
Schering-Plough Corporation
COO and SVP of Research and Development
Biolex
One-to-One Meetings
The streamlined and professional flow of the day is based on a simple format: our summit team works closely with a committee of industry executives (end users, not vendors) who select and invite their peers from established and upcoming companies, from incumbent to breakthrough SME.
Our business analysts and our analyst partners talk with the invited executives to discover their most pressing strategy and technology demands.
We then match these demands with the leading solutions and services available in the market and invite only appropriate companies to participate.
Each company engages in a number of executive one-to-one business solution briefings, plus panel discussions, fine dining and unlimited networking over the three-day event.
Testimonials
"This was a fantastic opportunity to meet our target market in one-on-one meetings, where we could listen to the customers’ challenges. A sort of voice of customer meets speed-dating event."
Mark Collins, Thermo Fisher
Source: www.ngpsummit.com© 2013 GDS International Ltd. All rights reserved.
